Sonoma Pharmaceuticals (SNOA) vs Vivos Therapeutics (VVOS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Sonoma Pharmaceuticals is the larger company by market cap ($5.6 million vs $5.0 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | SNOA | VVOS |
|---|---|---|
| Share price | $1.17 | $0.1501 |
| Market cap | $5.60M | $5.04M |
| 1-day change | +0.86% | +0.40% |
| EPS (TTM) | $-1.22 | $-1.88 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $4.30 | $3.28 |
| 52-week low | $0.85 | $0.129 |
| Distance from 52-week high | -72.79% | -95.42% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +1312.39% |
| Average volume | 107.65K | 12.57M |
| Shares outstanding | 4.79M | 33.61M |
| Employees | 10 | 268 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Sonoma Pharmaceuticals
SNOA stock →Sonoma Pharmaceuticals, Inc. develops and produces stabilized hypochlorous acid (HOCl) products for wound and eye care, oral and nasal care, podiatry, animal health care, and dermatological conditions in the United States, Europe, Asia, Latin America, and internationally.
Health Care · Medical/Dental Instruments · 10 employees
About Vivos Therapeutics
VVOS stock →Vivos Therapeutics, Inc. operates as a medical technology and healthcare services company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults.
Health Care · Medical/Dental Instruments · 268 employees
SNOA vs VVOS FAQ
Which is bigger, Sonoma Pharmaceuticals or Vivos Therapeutics?
Sonoma Pharmaceuticals (SNOA) is larger, with a market capitalization of $5.60M compared with $5.04M for Vivos Therapeutics (VVOS).
Are Sonoma Pharmaceuticals and Vivos Therapeutics in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.